| 000 | 01467 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513225405.0 | ||
| 264 | 0 | _c20010208 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s001250051543 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVay, D | |
| 245 | 0 | 0 |
_aAntibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients. _h[electronic resource] |
| 260 |
_bDiabetologia _cNov 2000 |
||
| 300 |
_a1385-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _ximmunology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSerum Albumin _ximmunology |
| 700 | 1 | _aVidali, M | |
| 700 | 1 | _aAllochis, G | |
| 700 | 1 | _aCusaro, C | |
| 700 | 1 | _aRolla, R | |
| 700 | 1 | _aMottaran, E | |
| 700 | 1 | _aBellomo, G | |
| 700 | 1 | _aAlbano, E | |
| 773 | 0 |
_tDiabetologia _gvol. 43 _gno. 11 _gp. 1385-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s001250051543 _zAvailable from publisher's website |
| 999 |
_c11066796 _d11066796 |
||